Oruka Therapeutics Inc (ORKA) returns
Oruka Therapeutics returns over 10 years
$1,000 invested in Oruka Therapeutics ten years ago was worth $335.38 at the close on October 30, 2026, with dividends reinvested: an average return of -10.3% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +16.3% | — | $1,163 | -0.9% |
| 3 months | -1.0% | — | $989.88 | +2.1% |
| Year to date | +219.6% | — | $3,196 | +11.7% |
| 1 year | +244.6% | — | $3,446 | +12.4% |
| 3 years | +637.8% | +94.7% | $7,378 | +88.5% |
| 5 years | +384.7% | +37.1% | $4,847 | +76.0% |
| 10 years | -66.5% | -10.3% | $335.38 | +316.6% |
Oruka Therapeutics return by calendar year
| Year | ORKA | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +219.6% | +11.7% | +207.9% |
| 2025 | +56.3% | +17.7% | +38.6% |
| 2024 | +56.4% | +24.9% | +31.5% |
| 2023 | -28.3% | +26.2% | -54.5% |
| 2022 | +10.2% | -18.2% | +28.4% |
| 2021 | -46.4% | +28.7% | -75.1% |
| 2020 | -29.8% | +18.4% | -48.1% |
| 2019 | -4.9% | +31.2% | -36.1% |
| 2018 | -75.3% | -4.6% | -70.7% |
| 2017 | -52.6% | +21.7% | -74.3% |
| 2016 | -38.7% | +12.0% | -50.7% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Oruka Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.